Certified by Founder Lodge
Bain Capital
United States - Boston, MA
INVESTOR
1 Disclosed Funding Rounds $12,500,000
302 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Bain Capital is one of the world’s leading alternative investment firms. More than 1,200 Bain Capital employees work together at locations in Boston, Chicago, New York, San Francisco, Palo Al
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 16 ,2022 | Series A | $12,500,000.00 |
| Company | Date | Round | Raised |
|---|---|---|---|
 Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
 Atmos |
November, 16 ,2022 | Series A | $12,500,000 |
 CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
 PeopleFund |
January, 18 ,2023 | Series C | $20,000,000 |
 Surf Internet |
February, 13 ,2023 | Unknown | $100,000,000 |
 Nimbus Therapeutics |
September, 13 ,2022 | Unknown | $125,000,000 |
 Releaf |
January, 13 ,2023 | Pre Series A | $3,300,000 |
 SumUp |
June, 23 ,2022 | Unknown | $624,000,000 |
| SumUp |
June, 23 ,2022 | Unknown | $624,000,000 |
 Alloy Automation |
March, 01 ,2022 | Unknown | $27,000,000 |
 Overview |
February, 21 ,2022 | Series A | $10,000,000 |
| PeopleFund |
January, 18 ,2023 | Series C | $20,000,000 |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
| Surf Internet |
February, 13 ,2023 | Unknown | $100,000,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
 Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
 Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| Nimbus Therapeutics |
September, 13 ,2022 | Unknown | $125,000,000 |
| Atmos |
November, 16 ,2022 | Series A | $12,500,000 |
| SumUp |
June, 23 ,2022 | Unknown | $624,000,000 |
| Releaf |
January, 13 ,2023 | Pre Series A | $3,300,000 |
| Alloy Automation |
March, 01 ,2022 | Unknown | $27,000,000 |
| Surf Internet |
February, 13 ,2023 | Unknown | $100,000,000 |
| PeopleFund |
January, 18 ,2023 | Series C | $20,000,000 |
| Overview |
February, 21 ,2022 | Series A | $10,000,000 |
| Surf Internet |
February, 13 ,2023 | Unknown | $100,000,000 |
| SumUp |
June, 23 ,2022 | Unknown | $624,000,000 |
| Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
| Alloy Automation |
March, 01 ,2022 | Unknown | $27,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
| Atmos |
November, 16 ,2022 | Series A | $12,500,000 |
 HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Releaf |
January, 13 ,2023 | Pre Series A | $3,300,000 |
| Nimbus Therapeutics |
September, 13 ,2022 | Unknown | $125,000,000 |
| Surf Internet |
February, 13 ,2023 | Unknown | $100,000,000 |
| PeopleFund |
January, 18 ,2023 | Series C | $20,000,000 |
| Overview |
February, 21 ,2022 | Series A | $10,000,000 |
| Alloy Automation |
March, 01 ,2022 | Unknown | $27,000,000 |
| SumUp |
June, 23 ,2022 | Unknown | $624,000,000 |
| Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
| Alloy Automation |
March, 01 ,2022 | Unknown | $27,000,000 |
| Surf Internet |
February, 13 ,2023 | Unknown | $100,000,000 |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
| Overview |
February, 21 ,2022 | Series A | $10,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| Nimbus Therapeutics |
September, 13 ,2022 | Unknown | $125,000,000 |
| SumUp |
June, 23 ,2022 | Unknown | $624,000,000 |
| PeopleFund |
January, 18 ,2023 | Series C | $20,000,000 |
| Releaf |
January, 13 ,2023 | Pre Series A | $3,300,000 |
| Alloy Automation |
March, 01 ,2022 | Unknown | $27,000,000 |
| Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
 Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| Surf Internet |
February, 13 ,2023 | Unknown | $100,000,000 |
| Overview |
February, 21 ,2022 | Series A | $10,000,000 |
| Overview |
February, 21 ,2022 | Series A | $10,000,000 |
| Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| Alloy Automation |
March, 01 ,2022 | Unknown | $27,000,000 |
| SumUp |
June, 23 ,2022 | Unknown | $624,000,000 |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
| Releaf |
January, 13 ,2023 | Pre Series A | $3,300,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| Surf Internet |
February, 13 ,2023 | Unknown | $100,000,000 |
| Overview |
February, 21 ,2022 | Series A | $10,000,000 |
| PeopleFund |
January, 18 ,2023 | Series C | $20,000,000 |
| Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
 LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| Alloy Automation |
March, 01 ,2022 | Unknown | $27,000,000 |
| Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Overview |
February, 21 ,2022 | Series A | $10,000,000 |
| Surf Internet |
February, 13 ,2023 | Unknown | $100,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| PeopleFund |
January, 18 ,2023 | Series C | $20,000,000 |
| SumUp |
June, 23 ,2022 | Unknown | $624,000,000 |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| Alloy Automation |
March, 01 ,2022 | Unknown | $27,000,000 |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
 ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
| Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
| Overview |
February, 21 ,2022 | Series A | $10,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
| SumUp |
June, 23 ,2022 | Unknown | $624,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Alloy Automation |
March, 01 ,2022 | Unknown | $27,000,000 |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| Surf Internet |
February, 13 ,2023 | Unknown | $100,000,000 |
| Overview |
February, 21 ,2022 | Series A | $10,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
 EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| Surf Internet |
February, 13 ,2023 | Unknown | $100,000,000 |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| Overview |
February, 21 ,2022 | Series A | $10,000,000 |
| Alloy Automation |
March, 01 ,2022 | Unknown | $27,000,000 |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
 1440 Foods |
December, 19 ,2023 | Unknown | |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Alloy Automation |
March, 01 ,2022 | Unknown | $27,000,000 |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Overview |
February, 21 ,2022 | Series A | $10,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
 Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| Overview |
February, 21 ,2022 | Series A | $10,000,000 |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
 Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
 Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
 Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
 Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
 Bridge(US) |
October, 28 ,2025 | Seed | $5,100,000 |
| Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| Bridge(US) |
October, 28 ,2025 | Seed | $5,100,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Bridge(US) |
October, 28 ,2025 | Seed | $5,100,000 |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
 Syremis Therapeutics |
December, 19 ,2025 | Series A | $165,000,000 |
| Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
| Bridge(US) |
October, 28 ,2025 | Seed | $5,100,000 |
| Syremis Therapeutics |
December, 19 ,2025 | Series A | $165,000,000 |
Founderpath
Truework
Finix
Farther
TeamApt Inc.
StretchSense | $2,300,000 | (Dec 23, 2025)
Ciphero | $2,500,000 | (Dec 23, 2025)
LatentForce | $1,700,000 | (Dec 23, 2025)
ZeroPhase | $6,800,000 | (Dec 23, 2025)
beycome | $2,500,000 | (Dec 23, 2025)
